{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:09:10Z","timestamp":1778926150597,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005054","name":"Nantong University","doi-asserted-by":"publisher","award":["2022LZ011"],"award-info":[{"award-number":["2022LZ011"]}],"id":[{"id":"10.13039\/501100005054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tranon.2026.102770","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:37:07Z","timestamp":1776177427000},"page":"102770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of MYC co-expression gene: POLR3G is associated with cell senescence, immunotherapy, chemotherapy responses, and clinical prognosis in bladder cancer patients"],"prefix":"10.1016","volume":"68","author":[{"given":"Li","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-3360","authenticated-orcid":false,"given":"Jibin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirong","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0001","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1186\/s12885-025-15010-1","article-title":"Elucidating a novel prognostic signature for bladder cancer by integrating hypoxia and lactate metabolism-related genes: comprehensive bioinformatics analyses and experimental evidence","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2026.102770_bib0002","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102770_bib0003","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2026.102770_bib0004","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-025-01854-1","article-title":"LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK\/ERK1\/2\/JNK signaling pathway","volume":"26","author":"Li","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"10","key":"10.1016\/j.tranon.2026.102770_bib0006","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1096\/fj.201900078RR","article-title":"LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC","volume":"33","author":"Zhuang","year":"2019","journal-title":"Faseb J."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0007","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41467-023-38160-x","article-title":"DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.tranon.2026.102770_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207710","article-title":"MYC as a multifaceted regulator of tumor microenvironment leading to metastasis","volume":"21","author":"Me\u0161kyt\u0117","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.tranon.2026.102770_bib0009","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708163","article-title":"An FGFR3\/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers","volume":"10","author":"Mahe","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.tranon.2026.102770_bib0010","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.7150\/thno.102730","article-title":"DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.tranon.2026.102770_bib0011","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.12659\/MSM.917345","article-title":"Forkhead Box R2 knockdown decreases chemoresistance to cisplatin via MYC pathway in bladder cancer","volume":"25","author":"Li","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0012","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41746-025-01930-6","article-title":"Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: advancing precision oncology","volume":"8","author":"Wang","year":"2025","journal-title":"NPJ Digit. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0013","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12672-025-02093-2","article-title":"SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and mendelian randomization analysis","volume":"16","author":"Gu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.tranon.2026.102770_bib0014","article-title":"ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysis","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s12916-025-04348-9","article-title":"Large language models in clinical trials: applications, technical advances, and future directions","volume":"23","author":"Lin","year":"2025","journal-title":"BMC Med."},{"issue":"20","key":"10.1016\/j.tranon.2026.102770_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17203291","article-title":"Lead exposure and bladder cancer: molecular insights from TCGA RNA-seq and toxicogenomic integration","volume":"17","author":"\u00d6ztan","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0017","article-title":"Single-cell RNA sequencing identifies potential critical prognostic biomarkers in bladder carcinoma","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.102770_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2025.09.002","article-title":"Bisphenol A exposure promotes proliferation and invasion capabilities of bladder cancer cells: insights from gene expression and pathway analysis","volume":"413","author":"Cong","year":"2025","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0019","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s12672-025-03709-3","article-title":"Circulating metabolites and bladder cancer: a Mendelian randomization and multi-omics study","volume":"16","author":"Chang","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0020","article-title":"Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer","volume":"57","author":"Zhang","year":"2025","journal-title":"Ann. Med."},{"issue":"14","key":"10.1016\/j.tranon.2026.102770_bib0021","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.tranon.2026.102770_bib0022","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0023","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1186\/s12967-025-06754-2","article-title":"DSG3 promotes bladder cancer growth and metastasis via AKT\/GSK3\u03b2\/\u03b2-catenin pathway","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0024","article-title":"A novel efferocytosis-related gene signature for predicting prognosis and therapeutic response in bladder cancer","volume":"15","author":"Yu","year":"2025","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.tranon.2026.102770_bib0025","article-title":"SUMOylation of SETD8 promotes tumor growth by methylating and stabilizing MYC in bladder cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-025-03325-7","article-title":"CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis","volume":"44","author":"Shen","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102770_bib0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","article-title":"USP43 stabilizes c-MYC to promote glycolysis and metastasis in bladder cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"15","key":"10.1016\/j.tranon.2026.102770_bib0028","first-page":"7408","article-title":"Senescence-related gene c-MYC affects bladder cancer cell senescence by interacting with HSP90B1 to regulate cisplatin sensitivity","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.tranon.2026.102770_bib0029","doi-asserted-by":"crossref","first-page":"669","DOI":"10.21873\/invivo.13871","article-title":"Imipramine-induced apoptosis and metastasis inhibition in human bladder cancer T24 cells through EGFR\/ERK\/NF-\u03bab pathway suppression","volume":"39","author":"Wang","year":"2025","journal-title":"In Vivo"},{"issue":"5","key":"10.1016\/j.tranon.2026.102770_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167811","article-title":"TNF-\u03b1 drives bladder cancer metastasis via METTL3-mediated m6A modification to promote CLASP2\/IQGAP1-dependent cytoskeleton remodeling","volume":"1871","author":"Chen","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.tranon.2026.102770_bib0031","first-page":"1059","article-title":"A prognostic impact of interleukin 17 (IL-17) as an immune-marker in patients with bladder cancer","volume":"77","author":"Mousa","year":"2022","journal-title":"Arch. Razi Inst."},{"issue":"2","key":"10.1016\/j.tranon.2026.102770_bib0032","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00432-025-06109-w","article-title":"CDCA4 promotes bladder cancer progression by JAK\/STAT signaling pathway","volume":"151","author":"Wan","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102770_bib0033","article-title":"Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102770_bib0034","article-title":"Understanding the relationship between cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Immunol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:22:34Z","timestamp":1778923354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S1936523326001075"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102770","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of MYC co-expression gene: POLR3G is associated with cell senescence, immunotherapy, chemotherapy responses, and clinical prognosis in bladder cancer patients","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102770"}}